Asia Pacific Influenza Vaccines Market : Table of Contents

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Influenza Vaccines Market – By Vaccine Type

1.3.2 Asia Pacific Influenza Vaccines Market – By Virus Type

1.3.3 Asia Pacific Influenza Vaccines Market – By Technology

1.3.4 Asia Pacific Influenza Vaccines Market – By Route of Administration

1.3.5 Asia Pacific Influenza Vaccines Market – By Target Group

1.3.6 Asia Pacific Influenza Vaccines Market – By Country

2. Asia Pacific Influenza Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Influenza Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Government Support to Promote Influenza Vaccination

5.1.2 Increasing Investment by Top Market Players and Governments

5.2 Market Restraints

5.2.1 High Cost of Vaccine Development

5.3 Market Opportunities

5.3.1 Emerging Economies

5.4 Future Trends

5.4.1 Strong Pipeline Candidates for Influenza Vaccines

5.5 Impact Analysis

6. Influenza Vaccine Market – Asia Pacific Analysis

6.1 Asia Pacific Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2 Asia Pacific Influenza Vaccines Market Revenue Forecasts And Analysis

6.2.1 Asia Pacific : Influenza Vaccines Market, 2019–2028 (US$ Million)

7. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1 Overview

7.2 Asia Pacific Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

7.3 Quadrivalent Vaccines

7.3.1 Overview

7.3.2 Quadrivalent Vaccines : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Trivalent Vaccines

7.4.1 Overview

7.4.2 Trivalent Vaccines : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1 Overview

8.2 Asia Pacific Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

8.3 Influenza Virus Type A

8.3.1 Overview

8.3.2 Influenza Virus Type A : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Influenza Virus Type B

8.4.1 Overview

8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1 Overview

9.2 Asia Pacific Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.3 Egg-based

9.3.1 Overview

9.3.2 Egg-based : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Cell-based

9.4.1 Overview

9.4.2 Cell-based : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1 Overview

10.2 Asia Pacific Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

10.3 Injection

10.3.1 Overview

10.3.2 Injection : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Nasal Spray

10.4.1 Overview

10.4.2 Nasal Spray: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1 Overview

11.2 Asia Pacific Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3 Infants

11.3.1 Overview

11.3.2 Infants : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Children

11.4.1 Overview

11.4.2 Children: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Adults

11.5.1 Overview

11.5.2 Adults : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Elderly People

11.6.1 Overview

11.6.2 Elderly People: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1 Asia Pacific: Influenza Vaccines Market

12.1.1 Overview

12.1.3 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

12.1.3.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.1.1 Overview

12.1.3.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.2.1 Overview

12.1.3.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.2.7 China: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.3.1 Overview

12.1.3.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.3.7 India: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.4.1 Overview

12.1.3.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.5.1 Overview

12.1.3.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

12.1.3.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.6 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.6.1 Overview

12.1.3.6.2 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

12.1.3.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

12.1.3.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

12.1.3.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.1.3.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13. Asia Pacific Influenza Vaccine Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Moderna, Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 SEQIRUS

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sanofi

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 GlaxoSmithKline plc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Hualan Biological Engineering Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Emergent BioSolutions Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Mitsubishi Chemical Group Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Serum Institute of India Pvt. Ltd

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 MYLAN N.V.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 AstraZeneca

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Influenza Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Table 2. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).

Table 3. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 4. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 5. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)

Table 6. Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 8. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 9. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 11. Japan Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 12. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 13. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 14. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 15. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 16. China Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 17. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 18. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 19. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 20. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 21. India Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 23. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 24. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 25. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 26. South Korea Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 27. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 28. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 29. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 30. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 31. Australia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)

Table 33. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)

Table 34. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 35. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 36. Rest of Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 37. Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 38. Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 39. Glossary of Terms, Influenza Vaccines Market

LIST OF FIGURES

Figure 1. Asia Pacific Influenza Vaccines Market Segmentation

Figure 2. Asia Pacific Influenza Vaccines Market Segmentation, by Country

Figure 3. Asia Pacific Influenza Vaccines Market Overview

Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Asia Pacific Influenza Vaccines Market

Figure 5. China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Asia Pacific: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Asia Pacific Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9. Asia Pacific Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10. Quadrivalent Vaccines: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Trivalent Vaccines: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Asia Pacific Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13. Influenza Virus Type A : Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Asia Pacific Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16. Egg-based: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Cell-based: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Asia Pacific Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19. Injection: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Nasal Spray: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Asia Pacific Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22. Infants : Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Children: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Adults: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Elderly People: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)

Figure 27. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

Figure 28. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Growth Strategies in the Influenza Vaccine Market, 2021-2028